Both rates remain acceptable and significantly lower than many older weight loss medications
Patients get it with an injectable pen and prefilled doses
This personalized insight helps your care team optimize your dose timing and nutrition strategy for your fastest safe results
Eli Lilly has indicated detailed results will be presented at the American Diabetes Association Scientific Sessions in June 2026
Effects on Obesity Obesity, as a chronic recurrent disease, is known to increase the risk of developing T2MD, hypertension, dyslipidemias, CVDs, NAFLD, and other diseases, leading to a poor quality of life and increased mortality (167)
This is because the medication is typically started at a lower dose and increased slowly over several weeks